BBCA Cardiovascular Medication Drug Ibutilide Fumarate Injection
Ibutilide Fumarate Injection
colorless or nearly colorless transparent liquid.
Ibutilide Fumarate Injection is used to reverse atrial fibrillation or atrial flutter to reverse sinus rhythm. Patients with chronic atrial arrhythmia are not sensitive to Ibutilide. Ibutilide's effect on arrhythmia patients over 90 days has not yet been determined.
This product should be stopped immediately in the following cases: cardiac arrhythmia disappeared; continuous or intermittent ventricular tachycardia; QT or Qtc was significantly prolonged. The recommended dose of Ibutilide injection was the first injection (10 minutes or more) for the second injection of 60 kg 1 (1 mg of fumaric acid Britt) for 10 minutes after the first injection of owSpan=2>. If the arrhythmia did not disappear, the equivalent dose could be injected again after the first injection of the first injection, and the injection time lasted for 10 minutes. After an injection of 60 kg 0.1 ml / kg (equivalent to 0.01 mg / kg of Britt fumaric acid), the patient should be monitored by continuous electrocardiogram for at least 4 hours, or when QTc is restored to the baseline. If obvious arrhythmia occurs, monitoring time should be prolonged. In the process of drug delivery and subsequent monitoring of the patient, experienced personnel and appropriate instruments, such as cardioverter / defibrillator, and the treatment of continuous ventricular tachycardia, including polymorphic ventricular tachycardia (detailed notes), must be provided. Britt's injection can be directly administered without dilution or diluted in 50 ml diluent. Britt can add 0.9% Sodium Chloride Injection or 5% Glucose Injection before giving the drug; the 1 10 ml package (0.1 mg / milliliter) of this product can be added to the 50 milliliter infusion package to form a mixture of about 0.017 milligrams / milliliters of Iran Britt. This product is a non intestinal drug. It should check whether there are granular objects and whether they are discolourated before using them at any time during the validity period of the solution or container.
Contact Person: Channing